Evidence map›Paper›PMID 30424817›Full record

ArticleInfectious diseases of poverty2018

The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol.

Gasim Abd-Elfarag, Makoy Yibi Logora, Jane Y Carter, Morrish Ojok, Jackson Songok, Sonia Menon, Ferdinand Wit, Richard Lako, Robert Colebunders

Open access · goldAbstract read
In one paragraph

Article in Infectious diseases of poverty, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Onchocerciasis Elimination: Progress and Challenges.Research and reports in tropical medicine · 2020
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Gasim Abd-ElfaragDepartment of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Makoy Yibi LogoraNeglected Tropical Diseases Unit, Ministry of Health, Juba, Republic of South Sudan.
Jane Y CarterAmref International University, Nairobi, Kenya.
Morrish OjokAmref Health Africa, Juba, South Sudan.
Jackson SongokAmref Health Africa, Juba, South Sudan.
Sonia MenonGlobal Health Institute, University of Antwerp, Antwerp, Belgium.
Ferdinand WitDepartment of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Richard LakoPolicy, Planning, Budgeting and Research, Ministry of Health, Juba, Republic of South Sudan.
Robert ColebundersGlobal Health Institute, University of Antwerp, Kinsbergen Centrum, Doornstraat 331, 2610, Antwerp, Belgium. robert.colebunders@uantwerpen.be.ORCID http://orcid.org/0000-0002-1919-1340
University of Juba · SSAmsterdam UMC Location University of Amsterdam · NLUniversity of Antwerp · BEAmref Health Africa · KE

Funding

H2020 European Research Council 6710055
6 · The paper itself

Abstract

backgroundNodding syndrome (NS) is a devastating epileptic illness of unknown aetiology mainly affecting children 5-15 years of age. Head nodding distinguishes NS from other forms of epilepsy. Other manifestations of the illness include mental and physical growth retardation. Many children die as a result of falling in fires or drowning. Recently, it was shown that NS is only one of the phenotypic presentations of onchocerciasis associated epilepsy (OAE). Despite the strong epidemiological association between epilepsy and onchocerciasis, the causal mechanism is unknown. After implementation of bi-annual community directed treatment with ivermectin (CDTi) and larviciding of rivers in northern Uganda, new cases of NS have ceased, while new cases continue to emerge in South Sudanese onchocerciasis-endemic areas with an interrupted CDTi programme. This study is designed to evaluate the potential effects of bi-annual CDTi on reducing the incidence of NS/OAE in onchocerciasis-endemic areas in South Sudan.

methodsA pre-intervention door-to-door population-based household survey will be conducted in selected onchocerciasis-endemic villages in Mundri and Maridi Counties, which have a high prevalence of epilepsy. Using a validated questionnaire, the entire village will be screened by community research assistants for suspected epilepsy cases. Suspected cases will be interviewed and examined by a trained clinical officer or medical doctor who will confirm or reject the diagnosis of epilepsy. Bi-annual CDTi will be implemented in the villages and a surveillance system for epilepsy set up. By implementing an epilepsy onchocerciasis awareness campaign we expect to obtain > 90% CDTi coverage of eligible individuals. The door-to-door survey will be repeated two years after the baseline survey. The incidence of NS/OAE will be compared before and after bi-annual CDTi. DISCUSSION: Our study is the first population-based study to evaluate the effect of bi-annual CDTi to reduce the incidence of NS/OAE. If the study demonstrates such a reduction, these findings are expected to motivate communities in onchocerciasis-endemic regions to participate in CDTi, and will encourage policy makers, funders and other stakeholders to increase their efforts to eliminate onchocerciasis.

Indexed as

AdolescentAntiparasitic AgentsChildChild, PreschoolEndemic DiseasesEpilepsyFemaleHumansIncidenceIvermectinMaleNodding SyndromeOnchocerciasisPrevalencePublic HealthSouth SudanAntiparasitic AgentsIvermectinCommunity directed treatmentEpilepsyIvermectinMaridiMundriNodding syndromeOnchocerciasisSouth Sudan

Identifiers

PMID30424817
PMCPMC6234538
OpenAlexW2898844346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.